[Immunological aspects of the treatment of various forms of Alzheimer's disease].
Leszek
J
J
Kowal-Gierczak
B
B
D000544:Alzheimer Disease / Q000145:classification / Q000276:immunology / Q000628:therapy*; D001323:Autoantibodies / Q000276:immunology; D001327:Autoimmune Diseases / Q000276:immunology / Q000628:therapy*; D001921:Brain / Q000187:drug effects / Q000276:immunology*; D003520:Cyclophosphamide / Q000627:therapeutic use; D004341:Drug Evaluation; D006801:Humans; D011760:Pyrrolidinones / Q000627:therapeutic use; D017981:Receptors, Neurotransmitter / Q000187:drug effects / Q000276:immunology*; D014165:Transfer Factor / Q000627:therapeutic use
D001323:Autoantibodies; D011760:Pyrrolidinones; D017981:Receptors, Neurotransmitter; D014165:Transfer Factor; D003520:Cyclophosphamide; C028537:2-pyrrolidone
Immunologiczne aspekty leczenia niektórych postaci choroby Alzheimera.